Come up with a name for your new list and we'll add to it:
Blackthorn Therapeutics raised a round of funding on June 20, 2017. Investors include
National Institutes of Health.
Blackthorn Therapeutics is developing targeted medicines for neurodevelopmental disorders. BlackThorn leverages its INFORM platform, which supports the discovery and development of targeted treatments…